Envestnet Asset Management
EWTX icon

Envestnet Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Envestnet Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$922K Buy
22,685
+6,955
+44% +$240K ﹤0.01% 3673
2026
Q1 		$495K Buy
+15,730
New +$454K ﹤0.01% 3941
2025
Q4 		– Sell
-10,837
Closed -$176K – 4525
2025
Q3 		$176K Buy
+10,837
New +$154K ﹤0.01% 4348
2025
Q2 		– Sell
-15,399
Closed -$339K – 4472
2025
Q1 		$339K Buy
15,399
+721
+5% +$18.9K ﹤0.01% 3856
2024
Q4 		$392K Buy
14,678
+3,561
+32% +$113K ﹤0.01% 3731
2024
Q3 		$297K Buy
+11,117
New +$221K ﹤0.01% 3831

Other funds holding EWTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Envestnet Asset Management's EWTX Position: Q2 2026 in Review

Envestnet Asset Management increased its Edgewise Therapeutics (EWTX) stake by 44% in Q2 2026, buying an estimated $240K and bringing the position to 22,685 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

Envestnet Asset Management first reported a position in EWTX in Q3 2024 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Envestnet Asset Management held 22,685 shares of Edgewise Therapeutics worth $922K as of Q2 2026.
  • Envestnet Asset Management bought 6,955 Edgewise Therapeutics shares in Q2 2026, an estimated $240K.
  • Edgewise Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3673 holding.
  • Envestnet Asset Management first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 37 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.